COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 875: Articles 8741-8750  | Next

Structural risk factors for SARS-CoV-2 infection in an urban slum: Age, gender and income
Fofana, M. O., Nery, N., Aguilar Ticona, P. P., Andrade Belitardo, E. M. M., Victoriano, R., Anjos, R. O., Portilho, M. M., de Santana, M. C., dos Santos, L. L., de Oliveira, D., Cruz, J. S., Muencker, M. C., Khouri, R., Wunder, E., Hitchings, M., Johnson, O., Reis, M. G., Riberiro, G. S., Cummings, D. A. T., Costa, F., Ko, A. I.
10.1101/2022.02.13.22270856 — Posted: 2022-02-15
Differential durability of humoral and T cell immunity after two and three BNT162b2 vaccinations in adults aged >80 years
Romero Olmedo, A. J., Schulz, A. R., Hochstaetter, S., Das Gupta, D., Hirseland, H., Staudenraus, D., Camara, B., Volland, K., Hefter, V., Sapre, S., Kraehling, V., Mueller-Kraeuter, H., Mei, H., Keller, C., Lohoff, M.
10.1101/2022.02.10.22270733 — Posted: 2022-02-15
Evaluation of test-to-return after COVID-19 diagnosis in a Massachusetts public school district
Nelson, S. B., Brenner, I. R., Homan, E., Lee, S. B., Bongiorno, C., Pollock, N., Ciaranello, A. L.
10.1101/2022.02.11.22270843 — Posted: 2022-02-15
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Lamacchia, G., Mazzoni, A., Spinicci, M., Vanni, A., Salvati, L., Peruzzi, B., Bencini, S., Capone, M., Carnasciali, A., Farahvachi, P., Rocca, A., Kiros, S. T., Graziani, L., Zammarchi, L., Mencarini, J., Colao, M. G., Caporale, R., Liotta, F., Cosmi, L., Rossolini, G. M., Bartoloni, A., Maggi, L., Annunziato, F.
10.1101/2022.02.14.22270857 — Posted: 2022-02-15
Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
Patriquin, G., LeBlanc, J. J., Gillis, H. A., McCracken, G. R., Pettipas, J. J., Hatchette, T. F.
10.1101/2022.02.13.22270891 — Posted: 2022-02-15
Predicting COVID-19 outbreak using open mobility data for minimal disruption on the country's economy
MORALES-FAJARDO, H. M., RODRIGUEZ-ARCE, J.
10.1101/2022.02.12.22270892 — Posted: 2022-02-15
SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, after the third wave, April-November 2021
Kleynhans, J., Tempia, S., Wolter, N., von Gottberg, A., Bhiman, J. N., Buys, A., Moyes, J., McMorrow, M. L., Kahn, K., Gomez-Olive, F. X., Tollman, S., Martinson, N. A., Wafawanaka, F., Lebina, L., du Toit, J., Jassat, W., Neti, M., Brauer, M., Cohen, C., the PHIRST-C Group
10.1101/2022.02.10.22270772 — Posted: 2022-02-15
Role of COVID-19 vaccinal status in admitted children during OMICRON variant circulation in Rio de Janeiro, city- Preliminary report
Araujo da Silva, A. R., de Carvalho, B. R. R., Esteves, M. d. M., Teixeira, C. H., Souza, C. V.
10.1101/2022.02.10.22270817 — Posted: 2022-02-15
Workplace infection control measures and romantic activities of workers during COVID-19 pandemic: a prospective cohort study in Japan
Fujino, Y., Okawara, M., Hino, A., Muramatsu, K., Nagata, T., Ikegami, K., Tateishi, S., Tsuji, M., Ishimaru, T.
10.1101/2022.02.13.22270825 — Posted: 2022-02-15
Strength and durability of antibody responses to BNT162b2 and CoronaVac
Cowling, B. J., Wong, I. O. L., Shiu, E. Y. C., Lai, A. Y. T., Cheng, S. M. S., Chaothai, S., Kwan, K. K. H., Martin-Sanchez, M., Poon, L. L. M., Ip, D. K. M., Leung, G. M., Leung, N. H. L., Peiris, M.
10.1101/2022.02.11.22270848 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).